In good agreement with our results, oral memantine treatment did not result in improved rotarod performance in the Ts65Dn mouse model of Down syndrome [55] or the G93A SOD1 mutation model of amyotrophic lateral sclerosis [56]. Here, SOD1 is linked to Down syndrome.